This study found that impaired kidney function was linked to increased plasma cerebral amyloidosis biomarkers, but ratio-based measures showed stable sensitivity and specificity for detecting cerebral amyloidosis across all eGFR groups.

This website uses a security service to protect against malicious bots. This page is displayed while the website verifies you are not a bot.